Trial intelligence / Profile preview

Effect of iron deficiency treatment on insulin resistance

IRCT20170215032587N3Phase 3Completed

Sponsor
Qom University of Medical Sciences
Start
May 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of Iron in iron deficiency anemia (IDA) and type 2 diabetes mellitus (T2DM), sponsored by Qom University of Medical Sciences. Started May 2018; status: completed.

02

Drugs

Iron
03

Conditions

iron deficiency anemia (IDA)type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on IRCT20170215032587N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170215032587N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call